| 000 | 01831 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516184905.0 | ||
| 264 | 0 | _c20141010 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1638-6183 | ||
| 024 | 7 |
_a10.1016/j.biochi.2013.12.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAuxietre, Thuy-Anh | |
| 245 | 0 | 0 |
_aSub-NOAEL amounts of vinclozolin and xenoestrogens target rat chondrogenesis in vivo. _h[electronic resource] |
| 260 |
_bBiochimie _cApr 2014 |
||
| 300 |
_a169-77 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xtoxicity |
| 650 | 0 | 4 |
_aBone Diseases, Developmental _xchemically induced |
| 650 | 0 | 4 |
_aCartilage _xabnormalities |
| 650 | 0 | 4 |
_aChondrogenesis _xdrug effects |
| 650 | 0 | 4 |
_aEndocrine Disruptors _xtoxicity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFungicides, Industrial _xtoxicity |
| 650 | 0 | 4 |
_aGenistein _xtoxicity |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNo-Observed-Adverse-Effect Level |
| 650 | 0 | 4 |
_aOxazoles _xtoxicity |
| 650 | 0 | 4 |
_aPhenols _xtoxicity |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPrenatal Exposure Delayed Effects _xchemically induced |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSpine _xabnormalities |
| 650 | 0 | 4 | _aX-Ray Microtomography |
| 650 | 0 | 4 |
_aXenobiotics _xtoxicity |
| 700 | 1 | _aDumontier, Marie-France | |
| 700 | 1 | _aBalguy, Irene | |
| 700 | 1 | _aFrapart, Yves | |
| 700 | 1 | _aCanivenc-Lavier, Marie-Chantal | |
| 700 | 1 | _aBerges, Raymond | |
| 700 | 1 | _aBoudalia, Sofiane | |
| 700 | 1 | _aAuger, Jacques | |
| 700 | 1 | _aCorvol, Marie-Therese | |
| 700 | 1 | _aSavouret, Jean-François | |
| 773 | 0 |
_tBiochimie _gvol. 99 _gp. 169-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biochi.2013.12.001 _zAvailable from publisher's website |
| 999 |
_c23363235 _d23363235 |
||